Dr. Terrell is the Chief Executive Officer of Austin-based Volition America and the Chief Medical Officer of the international parent company VolitionRx. Volition develops low-cost, easy-to-use, routine blood tests for cancer screening. Dr. Terrell is the Non-Executive Chairman for Kiromic Biopharma in Houston. Kiromic is currently conducting multiple clinical trials and is developing the world’s first off-the-shelf immunotherapies. Dr. Terrell is the Chief Medical and Scientific Officer for Generex Biotechnology, an integrated healthcare holding company providing physicians, hospitals, and providers comprehensive solutions for patient centric care from rapid diagnosis through delivery of personalized therapies, streamlining care processes, minimizing expenses, and delivering transparency for payers. Dr. Terrell is a faculty member at the UT Dell Medical School where he serves as an Expert Advisor for the Texas Health Catalyst Program.